Abstract

von Willebrand factor (VWF) is a multimeric protein consisting of covalently linked monomers, which share an identical domain architecture. Although involved in processes such as inflammation, angiogenesis, and cancer metastasis, VWF is mostly known for its role in hemostasis, by acting as a chaperone protein for coagulation factor VIII (FVIII) and by contributing to the recruitment of platelets during thrombus formation. To serve its role in hemostasis, VWF needs to bind a variety of ligands, including FVIII, platelet-receptor glycoprotein Ib-α, VWF-cleaving protease ADAMTS13, subendothelial collagen, and integrin α-IIb/β-3. Importantly, interactions are differently regulated for each of these ligands. How are these binding events accomplished and coordinated? The basic structures of the domains that constitute the VWF protein are found in hundreds of other proteins of prokaryotic and eukaryotic organisms. However, the determination of the 3-dimensional structures of these domains within the VWF context and especially in complex with its ligands reveals that exclusive, VWF-specific structural adaptations have been incorporated in its domains. They provide an explanation of how VWF binds its ligands in a synchronized and timely fashion. In this review, we have focused on the domains that interact with the main ligands of VWF and discuss how elucidating the 3-dimensional structures of these domains has contributed to our understanding of how VWF function is controlled. We further detail how mutations in these domains that are associated with von Willebrand disease modulate the interaction between VWF and its ligands.

1.
Sadler
JE
.
Biochemistry and genetics of von Willebrand factor
.
Annu Rev Biochem
.
1998
;
67
:
395
-
424
.
2.
Lenting
PJ
,
Casari
C
,
Christophe
OD
,
Denis
CV
.
von Willebrand factor: the old, the new and the unknown
.
J Thromb Haemost
.
2012
;
10
(
12
):
2428
-
2437
.
3.
Atiq
F
,
O'Donnell
JS
.
Novel functions for von Willebrand factor
.
Blood
.
2024
;
144
(
12
):
1247
-
1256
.
4.
Leebeek
FW
,
Eikenboom
JC
.
Von Willebrand's disease
.
N Engl J Med
.
2016
;
375
(
21
):
2067
-
2080
.
5.
Zhou
YF
,
Eng
ET
,
Zhu
J
,
Lu
C
,
Walz
T
,
Springer
TA
.
Sequence and structure relationships within von Willebrand factor
.
Blood
.
2012
;
120
(
2
):
449
-
458
.
6.
Lenting
PJ
,
Christophe
OD
,
Denis
CV
.
von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends
.
Blood
.
2015
;
125
(
13
):
2019
-
2028
.
7.
Springer
TA
.
von Willebrand factor, Jedi knight of the bloodstream
.
Blood
.
2014
;
124
(
9
):
1412
-
1425
.
8.
Zhang
X
,
Halvorsen
K
,
Zhang
CZ
,
Wong
WP
,
Springer
TA
.
Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor
.
Science
.
2009
;
324
(
5932
):
1330
-
1334
.
9.
Voorberg
J
,
Fontijn
R
,
van Mourik
JA
,
Pannekoek
H
.
Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization
.
EMBO J
.
1990
;
9
(
3
):
797
-
803
.
10.
Purvis
AR
,
Gross
J
,
Dang
LT
, et al
.
Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi
.
Proc Natl Acad Sci U S A
.
2007
;
104
(
40
):
15647
-
15652
.
11.
Anderson
JR
,
Li
J
,
Springer
TA
,
Brown
A
.
Structures of VWF tubules before and after concatemerization reveal a mechanism of disulfide bond exchange
.
Blood
.
2022
;
140
(
12
):
1419
-
1430
.
12.
Foster
PA
,
Fulcher
CA
,
Marti
T
,
Titani
K
,
Zimmerman
TS
.
A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor
.
J Biol Chem
.
1987
;
262
(
18
):
8443
-
8446
.
13.
Pipe
SW
,
Montgomery
RR
,
Pratt
KP
,
Lenting
PJ
,
Lillicrap
D
.
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A
.
Blood
.
2016
;
128
(
16
):
2007
-
2016
.
14.
Yee
A
,
Gildersleeve
RD
,
Gu
S
, et al
.
A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice
.
Blood
.
2014
;
124
(
3
):
445
-
452
.
15.
Leyte
A
,
Verbeet
MP
,
Brodniewicz-Proba
T
,
Van Mourik
JA
,
Mertens
K
.
The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII
.
Biochem J
.
1989
;
257
(
3
):
679
-
683
.
16.
Vlot
AJ
,
Koppelman
SJ
,
van den Berg
MH
,
Bouma
BN
,
Sixma
JJ
.
The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor
.
Blood
.
1995
;
85
(
11
):
3150
-
3157
.
17.
Dimitrov
JD
,
Christophe
OD
,
Kang
J
, et al
.
Thermodynamic analysis of the interaction of factor VIII with von Willebrand factor
.
Biochemistry
.
2012
;
51
(
20
):
4108
-
4116
.
18.
Jorieux
S
,
Gaucher
C
,
Goudemand
J
,
Mazurier
C
.
A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization
.
Blood
.
1998
;
92
(
12
):
4663
-
4670
.
19.
Hilbert
L
,
Jorieux
S
,
Proulle
V
, et al
.
Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity
.
Br J Haematol
.
2003
;
120
(
4
):
627
-
632
.
20.
Mazurier
C
,
Hilbert
L
.
Type 2N von Willebrand disease
.
Curr Hematol Rep
.
2005
;
4
(
5
):
350
-
358
.
21.
Castaman
G
,
Giacomelli
SH
,
Jacobi
P
, et al
.
Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype
.
J Thromb Haemost
.
2010
;
8
(
9
):
2011
-
2016
.
22.
Chiu
PL
,
Bou-Assaf
GM
,
Chhabra
ES
, et al
.
Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry
.
Blood
.
2015
;
126
(
8
):
935
-
938
.
23.
Yee
A
,
Oleskie
AN
,
Dosey
AM
, et al
.
Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII
.
Blood
.
2015
;
126
(
8
):
939
-
942
.
24.
Przeradzka
MA
,
van Galen
J
,
Ebberink
E
, et al
.
D' domain region Arg782-Cys799 of von Willebrand factor contributes to factor VIII binding
.
Haematologica
.
2020
;
105
(
6
):
1695
-
1703
.
25.
Fuller
JR
,
Knockenhauer
KE
,
Leksa
NC
,
Peters
RT
,
Batchelor
JD
.
Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy
.
Blood
.
2021
;
137
(
21
):
2970
-
2980
.
26.
Mazurier
C
,
Goudemand
J
,
Hilbert
L
,
Caron
C
,
Fressinaud
E
,
Meyer
D
.
Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology
.
Best Pract Res Clin Haematol
.
2001
;
14
(
2
):
337
-
347
.
27.
Swystun
LL
,
Georgescu
I
,
Mewburn
J
, et al
.
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice
.
J Thromb Haemost
.
2017
;
15
(
8
):
1607
-
1619
.
28.
Shi
Q
,
Fahs
SA
,
Mattson
JG
, et al
.
A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD
.
Blood Adv
.
2022
;
6
(
9
):
2778
-
2790
.
29.
Bendetowicz
AV
,
Morris
JA
,
Wise
RJ
,
Gilbert
GE
,
Kaufman
RJ
.
Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers
.
Blood
.
1998
;
92
(
2
):
529
-
538
.
30.
Eikenboom
JC
,
Castaman
G
,
Kamphuisen
PW
,
Rosendaal
FR
,
Bertina
RM
.
The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor
.
Thromb Haemost
.
2002
;
87
(
2
):
252
-
257
.
31.
Whittaker
CA
,
Hynes
RO
.
Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere
.
Mol Biol Cell
.
2002
;
13
(
10
):
3369
-
3387
.
32.
Huizinga
EG
,
Tsuji
S
,
Romijn
RA
, et al
.
Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain
.
Science
.
2002
;
297
(
5584
):
1176
-
1179
.
33.
Arce
NA
,
Cao
W
,
Brown
AK
, et al
.
Activation of von Willebrand factor via mechanical unfolding of its discontinuous autoinhibitory module
.
Nat Commun
.
2021
;
12
(
1
):
2360
.
34.
Lee
JO
,
Rieu
P
,
Arnaout
MA
,
Liddington
R
.
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18)
.
Cell
.
1995
;
80
(
4
):
631
-
638
.
35.
Celikel
R
,
Varughese
KI
,
Madhusudan
YA
,
Ware
J
,
Ruggeri
ZM
.
Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab
.
Nat Struct Biol
.
1998
;
5
(
3
):
189
-
194
.
36.
Emsley
J
,
Cruz
M
,
Handin
R
,
Liddington
R
.
Crystal structure of the von Willebrand Factor A1 domain and implications for the binding of platelet glycoprotein Ib
.
J Biol Chem
.
1998
;
273
(
17
):
10396
-
10401
.
37.
Ruggeri
ZM
,
Orje
JN
,
Habermann
R
,
Federici
AB
,
Reininger
AJ
.
Activation-independent platelet adhesion and aggregation under elevated shear stress
.
Blood
.
2006
;
108
(
6
):
1903
-
1910
.
38.
Dumas
JJ
,
Kumar
R
,
McDonagh
T
, et al
.
Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations
.
J Biol Chem
.
2004
;
279
(
22
):
23327
-
23334
.
39.
Blenner
MA
,
Dong
X
,
Springer
TA
.
Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib
.
J Biol Chem
.
2014
;
289
(
9
):
5565
-
5579
.
40.
Ju
L
,
Dong
JF
,
Cruz
MA
,
Zhu
C
.
The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibalpha
.
J Biol Chem
.
2013
;
288
(
45
):
32289
-
32301
.
41.
Tischer
A
,
Cruz
MA
,
Auton
M
.
The linker between the D3 and A1 domains of vWF suppresses A1-GPIbalpha catch bonds by site-specific binding to the A1 domain
.
Protein Sci
.
2013
;
22
(
8
):
1049
-
1059
.
42.
Deng
W
,
Wang
Y
,
Druzak
SA
, et al
.
A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor
.
J Thromb Haemost
.
2017
;
15
(
9
):
1867
-
1877
.
43.
Arce
NA
,
Markham-Lee
Z
,
Liang
Q
, et al
.
Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory module
.
Blood
.
2024
;
143
(
19
):
1992
-
2004
.
44.
Girma
JP
,
Takahashi
Y
,
Yoshioka
A
,
Diaz
J
,
Meyer
D
.
Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib
.
Thromb Haemost
.
1990
;
64
(
2
):
326
-
332
.
45.
Hulstein
JJ
,
de Groot
PG
,
Silence
K
,
Veyradier
A
,
Fijnheer
R
,
Lenting
PJ
.
A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B
.
Blood
.
2005
;
106
(
9
):
3035
-
3042
.
46.
Groot
E
,
de Groot
PG
,
Fijnheer
R
,
Lenting
PJ
.
The presence of active von Willebrand factor under various pathological conditions
.
Curr Opin Hematol
.
2007
;
14
(
3
):
284
-
289
.
47.
Ulrichts
H
,
Silence
K
,
Schoolmeester
A
, et al
.
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs
.
Blood
.
2011
;
118
(
3
):
757
-
765
.
48.
Peyvandi
F
,
Scully
M
,
Kremer Hovinga
JA
, et al
.
Caplacizumab for acquired thrombotic thrombocytopenic purpura
.
N Engl J Med
.
2016
;
374
(
6
):
511
-
522
.
49.
Chopek
MW
,
Girma
JP
,
Fujikawa
K
,
Davie
EW
,
Titani
K
.
Human von Willebrand factor: a multivalent protein composed of identical subunits
.
Biochemistry
.
1986
;
25
(
11
):
3146
-
3155
.
50.
Zhang
Q
,
Zhou
YF
,
Zhang
CZ
,
Zhang
X
,
Lu
C
,
Springer
TA
.
Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor
.
Proc Natl Acad Sci U S A
.
2009
;
106
(
23
):
9226
-
9231
.
51.
Jakobi
AJ
,
Mashaghi
A
,
Tans
SJ
,
Huizinga
EG
.
Calcium modulates force sensing by the von Willebrand factor A2 domain
.
Nat Commun
.
2011
;
2
:
385
.
52.
Zhou
M
,
Dong
X
,
Baldauf
C
, et al
.
A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13
.
Blood
.
2011
;
117
(
17
):
4623
-
4631
.
53.
Lynch
CJ
,
Lane
DA
,
Luken
BM
.
Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF
.
Blood
.
2014
;
123
(
16
):
2585
-
2592
.
54.
Morioka
Y
,
Casari
C
,
Wohner
N
, et al
.
Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in mice
.
Blood
.
2014
;
123
(
21
):
3344
-
3353
.
55.
Zanardelli
S
,
Chion
AC
,
Groot
E
, et al
.
A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF
.
Blood
.
2009
;
114
(
13
):
2819
-
2828
.
56.
Petri
A
,
Kim
HJ
,
Xu
Y
, et al
.
Crystal structure and substrate-induced activation of ADAMTS13
.
Nat Commun
.
2019
;
10
(
1
):
3781
.
57.
Crawley
JT
,
de Groot
R
,
Xiang
Y
,
Luken
BM
,
Lane
DA
.
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor
.
Blood
.
2011
;
118
(
12
):
3212
-
3221
.
58.
Xu
AJ
,
Springer
TA
.
Mechanisms by which von Willebrand disease mutations destabilize the A2 domain
.
J Biol Chem
.
2013
;
288
(
9
):
6317
-
6324
.
59.
Rayes
J
,
Hommais
A
,
Legendre
P
, et al
.
Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13
.
J Thromb Haemost
.
2007
;
5
(
2
):
321
-
328
.
60.
Shim
K
,
Anderson
PJ
,
Tuley
EA
,
Wiswall
E
,
Sadler
JE
.
Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress
.
Blood
.
2008
;
111
(
2
):
651
-
657
.
61.
Cao
W
,
Krishnaswamy
S
,
Camire
RM
,
Lenting
PJ
,
Zheng
XL
.
Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13
.
Proc Natl Acad Sci U S A
.
2008
;
105
(
21
):
7416
-
7421
.
62.
Van Belle
E
,
Rauch
A
,
Vincentelli
A
, et al
.
Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions
.
Circ Res
.
2015
;
116
(
7
):
1193
-
1201
.
63.
Van Belle
E
,
Rauch
A
,
Vincent
F
, et al
.
Von Willebrand factor multimers during transcatheter aortic-valve replacement
.
N Engl J Med
.
2016
;
375
(
4
):
335
-
344
.
64.
Lankhof
H
,
van Hoeij
M
,
Schiphorst
ME
, et al
.
A3 domain is essential for interaction of von Willebrand factor with collagen type III
.
Thromb Haemost
.
1996
;
75
(
6
):
950
-
958
.
65.
Huizinga
EG
,
Martijn van der Plas
R
,
Kroon
J
,
Sixma
JJ
,
Gros
P
.
Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding
.
Structure
.
1997
;
5
(
9
):
1147
-
1156
.
66.
Bienkowska
J
,
Cruz
M
,
Atiemo
A
,
Handin
R
,
Liddington
R
.
The von willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif
.
J Biol Chem
.
1997
;
272
(
40
):
25162
-
25167
.
67.
Romijn
RA
,
Westein
E
,
Bouma
B
, et al
.
Mapping the collagen-binding site in the von Willebrand factor-A3 domain
.
J Biol Chem
.
2003
;
278
(
17
):
15035
-
15039
.
68.
Lisman
T
,
Raynal
N
,
Groeneveld
D
, et al
.
A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides
.
Blood
.
2006
;
108
(
12
):
3753
-
3756
.
69.
Brondijk
TH
,
Bihan
D
,
Farndale
RW
,
Huizinga
EG
.
Implications for collagen I chain registry from the structure of the collagen von Willebrand factor A3 domain complex
.
Proc Natl Acad Sci U S A
.
2012
;
109
(
14
):
5253
-
5258
.
70.
Kizlik-Masson
C
,
Peyron
I
,
Gangnard
S
, et al
.
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD
.
Blood
.
2023
;
141
(
12
):
1457
-
1468
.
71.
Ribba
AS
,
Loisel
I
,
Lavergne
JM
, et al
.
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen
.
Thromb Haemost
.
2001
;
86
(
3
):
848
-
854
.
72.
Legendre
P
,
Navarrete
AM
,
Rayes
J
, et al
.
Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein
.
Blood
.
2013
;
121
(
11
):
2135
-
2143
.
73.
Riddell
AF
,
Gomez
K
,
Millar
CM
, et al
.
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
.
Blood
.
2009
;
114
(
16
):
3489
-
3496
.
74.
Flood
VH
,
Lederman
CA
,
Wren
JS
, et al
.
Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD
.
J Thromb Haemost
.
2010
;
8
(
6
):
1431
-
1433
.
75.
Shida
Y
,
Rydz
N
,
Stegner
D
, et al
.
Analysis of the role of von Willebrand factor, platelet glycoprotein VI-and alpha2beta1-mediated collagen binding in thrombus formation
.
Blood
.
2014
;
124
(
11
):
1799
-
1807
.
76.
Santoro
SA
.
Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen
.
Biochim Biophys Acta
.
1983
;
756
(
1
):
123
-
126
.
77.
Bendetowicz
AV
,
Wise
RJ
,
Gilbert
GE
.
Collagen-bound von Willebrand factor has reduced affinity for factor VIII
.
J Biol Chem
.
1999
;
274
(
18
):
12300
-
12307
.
78.
Bork
P
.
The modular architecture of a new family of growth regulators related to connective tissue growth factor
.
FEBS Lett
.
1993
;
327
(
2
):
125
-
130
.
79.
Garcia
Abreu J
,
Coffinier
C
,
Larrain
J
,
Oelgeschlager
M
,
De Robertis
EM
.
Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems
.
Gene
.
2002
;
287
(
1-2
):
39
-
47
.
80.
O'Leary
JM
,
Hamilton
JM
,
Deane
CM
,
Valeyev
NV
,
Sandell
LJ
,
Downing
AK
.
Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand factor type C module) from collagen IIA
.
J Biol Chem
.
2004
;
279
(
51
):
53857
-
53866
.
81.
Zhang
JL
,
Qiu
LY
,
Kotzsch
A
, et al
.
Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding
.
Dev Cell
.
2008
;
14
(
5
):
739
-
750
.
82.
Xu
ER
,
Blythe
EE
,
Fischer
G
,
Hyvonen
M
.
Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2
.
J Biol Chem
.
2017
;
292
(
30
):
12516
-
12527
.
83.
Xu
ER
,
von Bulow
S
,
Chen
PC
, et al
.
Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor
.
Blood
.
2019
;
133
(
4
):
366
-
376
.
84.
Ruggeri
ZM
,
De Marco
L
,
Gatti
L
,
Bader
R
,
Montgomery
RR
.
Platelets have more than one binding site for von Willebrand factor
.
J Clin Invest
.
1983
;
72
(
1
):
1
-
12
.
85.
Pietu
G
,
Cherel
G
,
Marguerie
G
,
Meyer
D
.
Inhibition of von Willebrand factor-platelet interaction by fibrinogen
.
Nature
.
1984
;
308
(
5960
):
648
-
649
.
86.
Lankhof
H
,
Wu
YP
,
Vink
T
, et al
.
Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor
.
Blood
.
1995
;
86
(
3
):
1035
-
1042
.
87.
Denis
C
,
Williams
JA
,
Lu
X
,
Meyer
D
,
Baruch
D
.
Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor
.
Blood
.
1993
;
82
(
12
):
3622
-
3630
.
88.
Konig
G
,
Obser
T
,
Marggraf
O
, et al
.
Alteration in GPIIb/IIIa binding of VWD-associated von Willebrand factor variants with C-terminal missense mutations
.
Thromb Haemost
.
2019
;
119
(
7
):
1102
-
1111
.
89.
Legendre
P
,
Delrue
M
,
Boisseau
P
, et al
.
Functional study of two mutations in the C4 domain of von Willebrand factor [abstract]
.
J Thromb Haemostas
.
2015
;
13
(
S2
):
748
.
90.
Marx
I
,
Christophe
OD
,
Lenting
PJ
, et al
.
Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa
.
Blood
.
2008
;
112
(
3
):
603
-
609
.
91.
Navarrete
AM
,
Casari
C
,
Legendre
P
, et al
.
A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor
.
Blood
.
2012
;
120
(
13
):
2723
-
2732
.
92.
Veyradier
A
,
Jumilly
AL
,
Ribba
AS
, et al
.
New assay for measuring binding of platelet glycoprotein IIb/IIIa to unpurified von Willebrand factor
.
Thromb Haemost
.
1999
;
82
(
1
):
134
-
139
.
93.
Fu
H
,
Jiang
Y
,
Yang
D
,
Scheiflinger
F
,
Wong
WP
,
Springer
TA
.
Flow-induced elongation of von Willebrand factor precedes tension-dependent activation
.
Nat Commun
.
2017
;
8
(
1
):
324
.
94.
Bergal
HT
,
Jiang
Y
,
Yang
D
,
Springer
TA
,
Wong
WP
.
Conformation of von Willebrand factor in shear flow revealed with stroboscopic single-molecule imaging
.
Blood
.
2022
;
140
(
23
):
2490
-
2499
.
95.
Savage
B
,
Sixma
JJ
,
Ruggeri
ZM
.
Functional self-association of von Willebrand factor during platelet adhesion under flow
.
Proc Natl Acad Sci U S A
.
2002
;
99
(
1
):
425
-
430
.
96.
Fu
H
,
Jiang
Y
,
Wong
WP
,
Springer
TA
.
Single-molecule imaging of von Willebrand factor reveals tension-dependent self-association
.
Blood
.
2021
;
138
(
23
):
2425
-
2434
.
97.
Chung
DW
,
Platten
K
,
Ozawa
K
, et al
.
Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association
.
Blood
.
2023
;
142
(
13
):
1156
-
1166
.
98.
Chung
DW
,
Chen
J
,
Ling
M
, et al
.
High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion
.
Blood
.
2016
;
127
(
5
):
637
-
645
.
99.
Zhang
C
,
Kelkar
A
,
Neelamegham
S
.
von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain
.
Blood Adv
.
2019
;
3
(
7
):
957
-
968
.
100.
Adam
F
,
Casari
C
,
Prevost
N
, et al
.
A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation
.
Sci Rep
.
2016
;
6
:
26306
.
You do not currently have access to this content.
Sign in via your Institution